MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bpa.13134

Медицинская библиотека · Brain pathology (Zurich, Switzerland) · 2022

Leigh syndrome is the main clinical characteristic of PTCD3 deficiency.

Muñoz-Pujol Gerard, Ortigoza-Escobar Juan D, Paredes-Fuentes Abraham J, Jou Cristina, Ugarteburu Olatz, Gort Laura, Yubero Delia, García-Cazorla Angels, O'Callaghan Mar, Campistol Jaume, Muchart Jordi, Yépez Vicente A, Gusic Mirjana, Gagneur Julien, Prokisch Holger, Artuch Rafael, Ribes Antonia, Urreizti Roser, Tort Frederic

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Mitochondrial translation defects are a continuously growing group of disorders showing a large variety of clinical symptoms including a wide range of neurological abnormalities. To date, mutations in PTCD3, encoding a component of the mitochondrial ribosome, have only been reported in a single individual with clinical evidence of Leigh syndrome. Here, we describe three additional PTCD3 individuals from two unrelated families, broadening the genetic and phenotypic spectrum of this disorder, and provide definitive evidence that PTCD3 deficiency is associated with Leigh syndrome. The patients presented in the first months of life with psychomotor delay, respiratory insufficiency and feeding difficulties. The neurologic phenotype included dystonia, optic atrophy, nystagmus and tonic-clonic seizures. Brain MRI showed optic nerve atrophy and thalamic changes, consistent with Leigh syndrome. WES and RNA-seq identified compound heterozygous variants in PTCD3 in both families: c.[1453-1G>C];[1918C>G] and c.[710del];[902C>T]. The functional consequences of the identified variants were determined by a comprehensive characterization of the mitochondrial function. PTCD3 protein levels were significantly reduced in patient fibroblasts and, consistent with a mitochondrial translation defect, a severe reduction in the steady state levels of complexes I and IV subunits was detected. Accordingly, the activity of these complexes was also low, and high-resolution respirometry showed a significant decrease in the mitochondrial respiratory capacity. Functional complementation studies demonstrated the pathogenic effect of the identified variants since the expression of wild-type PTCD3 in immortalized fibroblasts restored the steady-state levels of complexes I and IV subunits as well as the mitochondrial respiratory capacity. Additionally, minigene assays demonstrated that three of the identified variants were pathogenic by altering PTCD3 mRNA processing. The fourth variant was a frameshift leading to a truncated protein. In summary, we provide evidence of PTCD3 involvement in human disease confirming that PTCD3 deficiency is definitively associated with Leigh syndrome.

Для цитирования: Muñoz-Pujol Gerard, Ortigoza-Escobar Juan D, Paredes-Fuentes Abraham J, Jou Cristina, Ugarteburu Olatz, Gort Laura, Yubero Delia, García-Cazorla Angels, O'Callaghan Mar, Campistol Jaume, Muchart Jordi, Yépez Vicente A, Gusic Mirjana, Gagneur Julien, Prokisch Holger, Artuch Rafael, Ribes Antonia, Urreizti Roser, Tort Frederic. Leigh syndrome is the main clinical characteristic of PTCD3 deficiency.. Brain pathology (Zurich, Switzerland). 2022. DOI: 10.1111/bpa.13134.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.